Stock listing

OTC:GTHP Guided Therapeutics, Inc. Stock

Follow Guided Therapeutics, Inc. into a list and get an email when it puts out news.

Share price · OTC:GTHP

$0.10 USD -0.01 (-9.1%)

Close on Nov 20, 2026

Past year -60.0% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.10 – $0.10 USDNov 20, 2026
Volume
4,292 sharesNov 20, 2026
Market cap
$9.65M USDAt the close on Nov 20, 2026 · price × 96.54M shares outstanding
52-week range
$0.10 – $0.54 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$6,810 USDMedian day 6,600 shares · 11 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
Guided Therapeutics, Inc. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OTC:GTHP · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.10-0.01-9.1%$0.10$0.10$0.104,292
$0.11+0.008+7.8%$0.11$0.11$0.117,600
$0.102-0.008-7.3%$0.11$0.11$0.10134,000
$0.110.000.0%$0.11$0.11$0.113,200
$0.11-0.01-8.3%$0.10$0.11$0.1011,800
$0.12+0.019+18.8%$0.11$0.12$0.11102,600
$0.101-0.009-8.2%$0.11$0.11$0.1021,500
$0.110.000.0%$0.138$0.138$0.10107,800
$0.11+0.01+10.0%$0.10$0.138$0.10144,364
$0.100.000.0%$0.109$0.109$0.1056,000
$0.10-0.008-7.4%$0.13$0.13$0.1058,000
$0.108-0.042-28.0%$0.12$0.13$0.10299,500
$0.15+0.013+9.5%$0.15$0.15$0.15500
$0.137-0.013-8.7%$0.13$0.137$0.13276,000
$0.15+0.005+3.4%$0.15$0.15$0.1477,200
$0.145-0.002-1.4%$0.147$0.147$0.1451,000
$0.147+0.002+1.4%$0.15$0.15$0.1472,000
$0.145+0.013+9.8%$0.15$0.15$0.1451,100
$0.132-0.013-9.0%$0.132$0.132$0.1321,000
$0.145-0.025-14.7%$0.17$0.17$0.14510,300
$0.17+0.02+13.3%$0.15$0.17$0.14822,300
$0.15-0.04-21.1%$0.137$0.232$0.13713,400
$0.19+0.03+18.8%$0.16$0.195$0.155154,200
$0.16-0.03-15.8%$0.18$0.18$0.15310,800
$0.190.000.0%$0.19$0.19$0.19100
$0.190.000.0%$0.19$0.19$0.19600
$0.190.000.0%$0.19$0.19$0.190
$0.190.000.0%$0.19$0.19$0.190
$0.19+0.01+5.6%$0.19$0.19$0.193,500
$0.18-0.02-10.0%$0.20$0.20$0.1815,700
$0.20-0.03-13.0%$0.229$0.235$0.2022,300
$0.23+0.028+13.9%$0.22$0.23$0.2215,000
$0.2020.000.0%$0.202$0.202$0.2020
$0.202-0.018-8.2%$0.20$0.202$0.18140,500
$0.22-0.028-11.3%$0.18$0.24$0.1818,300
$0.2480.000.0%$0.248$0.248$0.2480
$0.248+0.048+24.0%$0.248$0.248$0.248100
$0.20+0.02+11.1%$0.248$0.248$0.1923,500
$0.18-0.068-27.4%$0.185$0.185$0.17745,900
$0.248+0.003+1.2%$0.182$0.248$0.18221,100
$0.2450.000.0%$0.245$0.245$0.2450
$0.245+0.025+11.4%$0.22$0.245$0.222,700
$0.220.000.0%$0.22$0.22$0.221,500
$0.22-0.01-4.3%$0.232$0.232$0.222,300
$0.230.000.0%$0.23$0.23$0.230
$0.23-0.02-8.0%$0.223$0.23$0.2235,200
$0.250.000.0%$0.25$0.25$0.250
$0.250.000.0%$0.22$0.25$0.221,900
$0.250.000.0%$0.25$0.25$0.250
$0.250.000.0%$0.25$0.25$0.250
$0.250.000.0%$0.25$0.25$0.250
$0.25+0.05+25.0%$0.20$0.25$0.18245,400
$0.200.000.0%$0.20$0.20$0.208,700
$0.20-0.038-16.0%$0.25$0.25$0.207,800
$0.238-0.012-4.8%$0.24$0.25$0.2156,600
$0.25+0.04+19.0%$0.19$0.25$0.1930,300
$0.21-0.015-6.7%$0.21$0.21$0.2110,000
$0.225-0.007-3.0%$0.23$0.23$0.2252,300
$0.232-0.003-1.3%$0.232$0.232$0.2321,100
$0.235-0.015-6.0%$0.235$0.235$0.213,500
$0.250.000.0%$0.25$0.25$0.250
$0.250.000.0%$0.24$0.25$0.1874,600
$0.25-0.02-7.4%$0.25$0.25$0.251,400
$0.270.000.0%$0.27$0.27$0.27100
$0.27+0.053+24.4%$0.19$0.27$0.1924,500

Splits

2 splits since 2016 · OTC:GTHP · every price before a split is adjusted for it

DayRatioWhat
1-for-800Consolidation
1-for-800Consolidation
Ticker
OTC:GTHP
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
OTC
Currency
USD

What changed lately

Latest news

All Guided Therapeutics, Inc. news

Guided Therapeutics, Inc. on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
1 in the last 12 months · 1 in all · newest Nov 4, 2026 · oldest 2026
Decks
9 decks · latest 2015

Valuation

EV/sales 14.2× against a median of 2.3×: 7th lowest of 10 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$9.68M USD
P/E
Loss
EV/sales
14.2×
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
Negative equity
Gross margin
80.2%
Operating margin
−304.0%
Net margin
−445.9%
Debt to equity
Negative equity
Beta vs S&P 500
-0.75

Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Guided Therapeutics, Inc. · OTC:GTHPUS$9.65MUS$9.68Mn/a14.2×n/an/a−445.9%n/a-0.75
Health & Life Co., Ltd. · TPEX:1781US$10.93MUS$10.03Mn/a0.8×n/a1.2×−12.7%0.6×n/a
Femasys Inc. · NASDAQ:FEMYUS$10.73M−US$8.31Mn/a−4.2×n/a0.4×−614.7%0.2×1.60
ADM Tronics Unlimited, Inc. · OTC:ADMTUS$9.97MUS$9.77Mn/a3.0×n/a13.4×−4.3%0.0×-1.45
United Health Products, Inc. · OTC:UEECUS$9.69MUS$9.69Mn/an/an/an/an/an/a-0.09
Nestmedic SA · NEWCONNECT:NSTUS$9.65MUS$9.24Mn/a38.8×n/a3.2×−413.6%0.0×n/a
EPS Bio Technology Corp. · TPEX:4183US$9.57MUS$5.77Mn/a0.4×21.4×1.2×−1.6%0.0×n/a
VVT Med Inc. · TSXV:VVTMUS$8.99MUS$8.99Mn/a93.6×n/an/an/an/a1.16
SpineGuard · EURONEXT:ALSGDUS$8.88MUS$9.65Mn/a2.3×n/a1.8×−55.0%0.3×n/a
Pulsenmore Ltd. · TASE:PLSMUS$8.71MUS$2.27Mn/a0.2×n/a0.3×−39.6%0.0×n/a
Conavi Medical Corp. · TSXV:CNVIUS$8.66MUS$8.89Mn/a15.1×n/an/an/an/a0.36
Median of the othersUS$9.61MUS$9.11M2.3×21.4×1.2×−39.6%0.0×0.36

Team and board

Officers

OfficerRole
Mark L. FaupelPresident and CEO, Board Member

Board

DirectorRole
Alan GrujicBoard Member
Mark L. FaupelPresident and CEO, Board Member
Richard P. BlumbergBoard Member

Events

QuarterResultsShare move
Q2 2025Aug 14, 2025+41.0%
Q1 2025May 12, 2025 · After close−4.8%
Q4 2024Mar 26, 2025 · After close+19.9%
Q3 2024Nov 11, 2024 · After close−7.7%
Q2 2024Aug 14, 2024 · After close+0.1%
Q1 2024May 13, 2024 · After close+15.3%
Q4 2023Mar 28, 2024 · After close+3.5%
Q3 2023Nov 13, 2023−3.9%
Q2 2023Aug 15, 2023+3.6%
Q1 2023May 15, 2023+11.7%
All 19 quarters
QuarterResultsShare move
Q4 2022Mar 10, 20230.0%
Q3 2022Nov 11, 2022−14.3%
Q2 2022Aug 11, 2022+5.8%
Q1 2022May 19, 2022−17.4%
Q4 2021Mar 15, 2022−5.8%
Quarter to Sep 30, 2021Nov 12, 2021−10.8%
Quarter to Jun 30, 2021Aug 12, 2021+60.0%
Quarter to Mar 31, 2021May 20, 2021+1.3%
Quarter to Dec 31, 2020Mar 16, 2021+2.3%

Open Events

Decks

DeckKindSlidesDate
Technical Presentation (2015)Technical20 slides2015
Technical Presentation (2014)Technical40 slides2014
Technical Presentation (2012)Technical35 slidesOct 4, 2012
ASCCP 2010Conference21 slides2010
Technical Presentation (2010)Technical18 slides2010
Technical Presentation (2010)Technical13 slides2010
Technical Presentation (2007)Technical35 slides2007
Technical Presentation (2006)Technical18 slides2006
EUROGIN 2003Conference18 slides2003

Open Decks

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue767.0K7.00K98.0K13.0K81.0K102.0K36.0K57.0K244.0K0
Cost of revenue196.0K5.00K62.0K81.0K61.0K-41.0K70.0K89.0K530.0K493.0K
Gross profit571.0K2.00K36.0K-68.0K20.0K143.0K-34.0K-32.0K-286.0K112.0K
Research and development469.0K526.0K228.0K77.0K69.0K143.0K122.0K244.0K334.0K733.0K
Operating income-2.37M-2.11M-3.46M-3.33M-2.36M-1.05M-937.0K-1.55M-3.12M-3.82M
Depreciation and amortization10.0K9.00K9.00K4.00K1.00K021.0K27.0K213.0K1.22M
EBITDA-2.36M-2.10M-3.45M-3.33M-2.36M-1.05M-916.0K-1.52M-2.91M-2.60M
Interest expense617.0K381.0K278.0K582.0K1.15M1.06M1.41M1.76M1.11M1.90M
Income before tax-3.20M-2.42M-3.49M-4.34M-2.07M-279.0K-1.92M1.02M-10.7M-3.97M
Income tax0000000000
Net income-3.20M-2.42M-3.49M-4.34M-2.07M-279.0K-1.92M1.02M-10.7M-3.97M
Earnings per share, basic-0.04-0.05-0.07-0.15-0.18-0.04-0.581.95997.64-24.62
Earnings per share, diluted-0.04-0.05-0.07-0.15-0.18-0.04-0.580.010.00-24.62

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents63.0K388.0K591.0K2.31M643.0K182.0K899.0K01.00K14.0K
Receivables4.00K3.00K7.00K6.00K46.0K
Inventory448.0K633.0K632.0K548.0K571.0K605.0K48.0K114.0K182.0K773.0K
Current assets605.0K1.20M1.39M3.00M1.64M896.0K1.03M196.0K297.0K1.05M
Property, plant and equipment16.0K23.0K32.0K42.0K14.0K1.00K021.0K49.0K126.0K
Total assets1.32M1.38M1.67M3.37M2.04M1.35M1.18M236.0K406.0K1.49M
Accounts payable2.42M2.09M1.99M2.19M2.36M2.42M2.90M3.01M3.02M2.60M
Current liabilities6.64M6.16M4.81M4.87M5.69M8.96M12.4M11.0M11.8M9.34M
Long-term debt022.0K23.0K0
Total debt017.0K22.0K23.0K6.35M5.74M9.05M
Total liabilities7.33M6.27M5.47M6.25M7.49M12.2M18.1M16.1M19.8M10.8M
Shareholders' equity-6.01M-4.89M-3.81M-2.88M-5.45M-10.9M-16.9M-15.8M-19.4M-9.27M
Shares outstanding86.2K65.1M54.1M48.6M13.7M13.1M3.32K2.67K62.0K669

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-1.07M-1.12M-1.75M-1.48M-1.59M-1.88M-806.0K-1.36M-1.14M-1.80M
Capital spending-2.00K00-31.0K-14.0K-1.00K00
Free cash flow-1.07M-1.12M-1.75M-1.51M-1.61M-1.88M-806.0K-1.80M
Cash from investing-2.00K0-31.0K-14.0K-1.00K00
Cash from financing745.0K916.0K24.0K3.18M2.07M1.16M1.71M1.36M1.13M1.78M
Change in cash-325.0K-203.0K-1.72M1.67M461.0K-717.0K899.0K-1.00K-13.0K-21.0K

Open Financials

Filings

FilingDateTypeFiled with
10-Q · Quarterly reportNov 16, 2026Quarterly reportSEC
4 · Change in ownershipOct 27, 2026Insider tradeSEC
10-Q · Quarterly reportAug 13, 2026Quarterly reportSEC
10-Q · Quarterly reportMay 15, 2026Quarterly reportSEC
4 · Change in ownershipMay 5, 2026Insider tradeSEC
4 · Change in ownershipApr 7, 2026Insider tradeSEC
4 · Change in ownershipApr 7, 2026Insider tradeSEC
4 · Change in ownershipApr 7, 2026Insider tradeSEC
10-K · Annual reportMar 30, 2026Annual reportSEC
4 · Change in ownershipMar 12, 2026Insider tradeSEC
Show 200 filings
FilingDateTypeFiled with
8-K · Current reportMar 9, 2026Material contractSEC
4 · Change in ownershipMar 4, 2026Insider tradeSEC
10-Q · Quarterly reportNov 13, 2025Quarterly reportSEC
4 · Change in ownershipSep 5, 2025Insider tradeSEC
4 · Change in ownershipSep 5, 2025Insider tradeSEC
4 · Change in ownershipSep 5, 2025Insider tradeSEC
4 · Change in ownershipSep 5, 2025Insider tradeSEC
10-Q · Quarterly reportAug 14, 2025Quarterly reportSEC
4 · Change in ownershipJun 13, 2025Insider tradeSEC
4 · Change in ownershipJun 12, 2025Insider tradeSEC
4 · Change in ownershipJun 12, 2025Insider tradeSEC
4/A · Change in ownership, amendedMay 23, 2025Insider tradeSEC
10-Q · Quarterly reportMay 15, 2025Quarterly reportSEC
4 · Change in ownershipApr 17, 2025Insider tradeSEC
4 · Change in ownershipApr 8, 2025Insider tradeSEC
10-K · Annual reportMar 31, 2025Annual reportSEC
4 · Change in ownershipFeb 18, 2025Insider tradeSEC
4 · Change in ownershipDec 20, 2024Insider tradeSEC
8-K · Current reportDec 20, 2024Material contractSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
10-Q · Quarterly reportNov 14, 2024Quarterly reportSEC
4 · Change in ownershipOct 25, 2024Insider tradeSEC
4 · Change in ownershipOct 24, 2024Insider tradeSEC
4 · Change in ownershipOct 2, 2024Insider tradeSEC
8-K · Current reportSep 26, 2024Material contractSEC
4 · Change in ownershipSep 9, 2024Insider tradeSEC
4 · Change in ownershipSep 6, 2024Insider tradeSEC
4 · Change in ownershipSep 4, 2024Insider tradeSEC
4 · Change in ownershipSep 3, 2024Insider tradeSEC
4 · Change in ownershipAug 23, 2024Insider tradeSEC
4 · Change in ownershipAug 22, 2024Insider tradeSEC
4 · Change in ownershipAug 22, 2024Insider tradeSEC
10-Q · Quarterly reportAug 14, 2024Quarterly reportSEC
4 · Change in ownershipAug 1, 2024Insider tradeSEC
10-Q · Quarterly reportMay 13, 2024Quarterly reportSEC
4 · Change in ownershipApr 19, 2024Insider tradeSEC
4 · Change in ownershipApr 5, 2024Insider tradeSEC
10-K · Annual reportMar 28, 2024Annual reportSEC
4 · Change in ownershipMar 22, 2024Insider tradeSEC
4 · Change in ownershipFeb 22, 2024Insider tradeSEC
SC 13G/A · Big-stake notice, amendedFeb 20, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2024Big-stake noticeSEC
4 · Change in ownershipDec 8, 2023Insider tradeSEC
10-Q · Quarterly reportNov 13, 2023Quarterly reportSEC
4 · Change in ownershipSep 20, 2023Insider tradeSEC
4 · Change in ownershipSep 11, 2023Insider tradeSEC
4 · Change in ownershipSep 7, 2023Insider tradeSEC
10-Q · Quarterly reportAug 10, 2023Quarterly reportSEC
4 · Change in ownershipJun 27, 2023Insider tradeSEC
4 · Change in ownershipJun 27, 2023Insider tradeSEC
4 · Change in ownershipJun 27, 2023Insider tradeSEC
4 · Change in ownershipJun 27, 2023Insider tradeSEC
4 · Change in ownershipJun 26, 2023Insider tradeSEC
4 · Change in ownershipJun 26, 2023Insider tradeSEC
4 · Change in ownershipJun 26, 2023Insider tradeSEC
3 · Initial statement of ownershipJun 20, 2023Insider tradeSEC
4 · Change in ownershipJun 2, 2023Insider tradeSEC
4 · Change in ownershipJun 2, 2023Insider tradeSEC
10-Q · Quarterly reportMay 15, 2023Quarterly reportSEC
10-K · Annual reportMar 29, 2023Annual reportSEC
8-K · Current reportMar 9, 2023Management or board changeSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2023Big-stake noticeSEC
EFFECT · Notice that a registration is effectiveJan 26, 2023Other filingsSEC
CORRESP · Letter to the SECJan 23, 2023Other filingsSEC
UPLOAD · Letter from the SECJan 23, 2023Other filingsSEC
S-1 · Registration statementJan 13, 2023Offer documentSEC
RW · Request to withdraw a registrationDec 2, 2022Other filingsSEC
10-Q · Quarterly reportNov 14, 2022Quarterly reportSEC
SC 13G · Big-stake noticeOct 24, 2022Big-stake noticeSEC
8-K · Current reportSep 15, 2022Material contractSEC
10-Q · Quarterly reportAug 15, 2022Quarterly reportSEC
8-K · Current reportJul 29, 2022Current reportSEC
S-1/A · Registration statement, amendedJul 12, 2022Offer documentSEC
SC 13G · Big-stake noticeJul 6, 2022Big-stake noticeSEC
S-1/A · Registration statement, amendedJun 29, 2022Offer documentSEC
10-Q · Quarterly reportMay 16, 2022Quarterly reportSEC
10-K · Annual reportMar 29, 2022Annual reportSEC
S-1/A · Registration statement, amendedFeb 17, 2022Offer documentSEC
8-K · Current reportJan 6, 2022Current reportSEC
10-Q · Quarterly reportNov 15, 2021Quarterly reportSEC
S-1/A · Registration statement, amendedOct 6, 2021Offer documentSEC
S-1 · Registration statementSep 28, 2021Offer documentSEC
8-K · Current reportSep 3, 2021Material contractSEC
10-Q · Quarterly reportAug 18, 2021Quarterly reportSEC
10-Q/A · Quarterly report, amendedAug 18, 2021Quarterly reportSEC
NT 10-Q · Late filing noticeAug 16, 2021Explanation requestSEC
8-K · Current reportJul 27, 2021Meeting outcomeSEC
10-K/A · Annual report, amendedJul 9, 2021Annual reportSEC
8-K · Current reportJul 7, 2021Current reportSEC
DEF 14A · Proxy statementJul 2, 2021Meeting noticeSEC
PRE 14A · Preliminary proxy statementJun 21, 2021Meeting noticeSEC
8-K · Current reportJun 10, 2021Material contractSEC
10-Q · Quarterly reportMay 20, 2021Quarterly reportSEC
NT 10-Q · Late filing noticeMay 17, 2021Explanation requestSEC
10-K · Annual reportApr 6, 2021Annual reportSEC
NT 10-K · Late filing noticeMar 31, 2021Explanation requestSEC
10-Q/A · Quarterly report, amendedNov 5, 2020Quarterly reportSEC
10-Q · Quarterly reportNov 5, 2020Quarterly reportSEC
EFFECT · Notice that a registration is effectiveOct 16, 2020Other filingsSEC
CORRESP · Letter to the SECOct 13, 2020Other filingsSEC
S-1/A · Registration statement, amendedOct 7, 2020Offer documentSEC
8-K · Current reportSep 16, 2020Management or board changeSEC
UPLOAD · Letter from the SECSep 14, 2020Other filingsSEC
S-1 · Registration statementSep 10, 2020Offer documentSEC
10-Q · Quarterly reportAug 19, 2020Quarterly reportSEC
NT 10-Q · Late filing noticeAug 17, 2020Explanation requestSEC
10-Q · Quarterly reportJul 7, 2020Quarterly reportSEC
NT 10-Q · Late filing noticeJun 29, 2020Explanation requestSEC
8-K · Current reportMay 18, 2020Current reportSEC
10-K · Annual reportApr 20, 2020Annual reportSEC
8-K · Current reportMar 31, 2020Current reportSEC
10-Q · Quarterly reportMar 9, 2020Quarterly reportSEC
10-Q · Quarterly reportFeb 11, 2020Quarterly reportSEC
NT 10-Q · Late filing noticeAug 15, 2019Explanation requestSEC
10-Q · Quarterly reportJul 11, 2019Quarterly reportSEC
NT 10-Q · Late filing noticeMay 15, 2019Explanation requestSEC
10-K · Annual reportMay 8, 2019Annual reportSEC
8-K · Current reportApr 3, 2019Management or board changeSEC
NT 10-K · Late filing noticeApr 1, 2019Explanation requestSEC
8-K · Current reportNov 14, 2018Current reportSEC
10-Q · Quarterly reportNov 14, 2018Quarterly reportSEC
8-K · Current reportOct 25, 2018Meeting outcomeSEC
DEF 14A · Proxy statementOct 11, 2018Meeting noticeSEC
PRE 14A · Preliminary proxy statementSep 28, 2018Meeting noticeSEC
DEF 14A · Proxy statementSep 17, 2018Meeting noticeSEC
8-K · Current reportSep 6, 2018Material contractSEC
PRE 14A · Preliminary proxy statementSep 5, 2018Meeting noticeSEC
10-Q · Quarterly reportAug 14, 2018Quarterly reportSEC
EFFECT · Notice that a registration is effectiveJul 11, 2018Other filingsSEC
CORRESP · Letter to the SECJul 9, 2018Other filingsSEC
UPLOAD · Letter from the SECJul 2, 2018Other filingsSEC
S-1 · Registration statementJun 14, 2018Offer documentSEC
SC 13D · Big-stake noticeMay 25, 2018Big-stake noticeSEC
3 · Initial statement of ownershipMay 25, 2018Insider tradeSEC
10-Q · Quarterly reportMay 21, 2018Quarterly reportSEC
NT 10-Q · Late filing noticeMay 15, 2018Explanation requestSEC
10-K/A · Annual report, amendedApr 20, 2018Annual reportSEC
10-K · Annual reportApr 17, 2018Annual reportSEC
NT 10-K · Late filing noticeApr 2, 2018Explanation requestSEC
10-Q · Quarterly reportNov 20, 2017Quarterly reportSEC
NT 10-Q · Late filing noticeNov 15, 2017Explanation requestSEC
8-K/A · Current report, amendedNov 9, 2017Material contractSEC
8-K · Current reportOct 25, 2017Material contractSEC
RW · Request to withdraw a registrationSep 25, 2017Other filingsSEC
8-K · Current reportAug 24, 2017Material contractSEC
10-Q · Quarterly reportAug 18, 2017Quarterly reportSEC
8-K/A · Current report, amendedAug 17, 2017Material contractSEC
NT 10-Q · Late filing noticeAug 15, 2017Explanation requestSEC
8-K · Current reportAug 14, 2017Material contractSEC
S-1/A · Registration statement, amendedJun 26, 2017Offer documentSEC
S-1/A · Registration statement, amendedJun 7, 2017Offer documentSEC
8-K · Current reportMay 23, 2017Material contractSEC
10-Q · Quarterly reportMay 19, 2017Quarterly reportSEC
NT 10-Q · Late filing noticeMay 15, 2017Explanation requestSEC
S-1/A · Registration statement, amendedMar 31, 2017Offer documentSEC
424B3 · ProspectusMar 30, 2017Offer documentSEC
8-K · Current reportMar 30, 2017Material contractSEC
424B3 · ProspectusMar 24, 2017Offer documentSEC
8-K/A · Current report, amendedMar 24, 2017Material contractSEC
10-K · Annual reportMar 22, 2017Annual reportSEC
SC 13G · Big-stake noticeMar 9, 2017Big-stake noticeSEC
424B3 · ProspectusFeb 16, 2017Offer documentSEC
8-K · Current reportFeb 16, 2017Material contractSEC
424B3 · ProspectusJan 26, 2017Offer documentSEC
8-K · Current reportJan 26, 2017Material contractSEC
S-1/A · Registration statement, amendedJan 12, 2017Offer documentSEC
424B3 · ProspectusDec 30, 2016Offer documentSEC
8-K · Current reportDec 30, 2016Material contractSEC
S-1/A · Registration statement, amendedDec 8, 2016Offer documentSEC
424B3 · ProspectusDec 8, 2016Offer documentSEC
8-K · Current reportDec 8, 2016Management or board changeSEC
424B3 · ProspectusDec 7, 2016Offer documentSEC
8-K · Current reportDec 7, 2016Material contractSEC
424B3 · ProspectusDec 5, 2016Offer documentSEC
10-Q · Quarterly reportDec 5, 2016Quarterly reportSEC
3 · Initial statement of ownershipNov 18, 2016Insider tradeSEC
424B3 · ProspectusNov 17, 2016Offer documentSEC
8-K · Current reportNov 17, 2016Management or board changeSEC
NT 10-Q · Late filing noticeNov 15, 2016Explanation requestSEC
424B3 · ProspectusNov 4, 2016Offer documentSEC
8-K · Current reportNov 4, 2016Material contractSEC
424B3 · ProspectusSep 23, 2016Offer documentSEC
8-K · Current reportSep 23, 2016Meeting outcomeSEC
424B3 · ProspectusSep 9, 2016Offer documentSEC
8-K/A · Current report, amendedSep 9, 2016Material contractSEC
424B3 · ProspectusSep 8, 2016Offer documentSEC
8-K · Current reportSep 8, 2016Material contractSEC
DEFA14A · Additional proxy materialAug 26, 2016Meeting noticeSEC
DEF 14A · Proxy statementAug 25, 2016Meeting noticeSEC
UPLOAD · Letter from the SECAug 19, 2016Other filingsSEC

This page holds 200 of 1,000 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Guided Therapeutics, Inc.’s releases

Common shares
96,537,349
Fully diluted
96,537,349

Fully diluted

LineShares
Common shares96,537,349

Share count over time

CountShares
Nov 22, 202696,537,349

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Gene S Cartwright
Other companies: Nanosphere Inc (Director · Jun 20, 2013 – Jun 30, 2016 · Past)
President & CEO, Director · Jan 6, 2014 – Jun 29, 2015 · Past
Alan GrujicBoard Member · Since at least Mar 7, 2023
John E ImhoffDirector · Since at least Sep 1, 2022
Jonathan M NiloffDirector · Nov 3, 2011 – Aug 14, 2014 · Past
Mark L. FaupelPresident and CEO, Board Member · Since at least Nov 4, 2026
Richard FowlerV.P. Engineering · Feb 9, 2011 – Jun 29, 2012 · Past
Richard P. BlumbergBoard Member · Since at least Nov 5, 2026
Ronald W HartDirector · Nov 3, 2011 – May 29, 2015 · Past

Open People

Log in to ask 6ix AI your own questions about Guided Therapeutics, Inc.